Genital Herpes Suppression Therapy refers to a treatment regimen designed to reduce the frequency and severity of outbreaks of genital herpes, a sexually transmitted infection caused primarily by the herpes simplex virus type 2 (HSV-2), though it can also be caused by type 1 (HSV-1).
This therapy typically involves the daily administration of antiviral medications, such as acyclovir, valacyclovir, or famciclovir. The goal of suppression therapy is to keep the virus in a dormant state, thereby minimizing the occurrence of symptomatic outbreaks and the risk of transmission to sexual partners.
Individuals on suppression therapy may experience a significant reduction in both the number and intensity of outbreaks, leading to improved quality of life and decreased anxiety associated with the condition. For example, a person who previously experienced multiple outbreaks per year may find that, with consistent therapy, they experience only one or none.
It’s important to note that while suppression therapy greatly reduces the risk of transmission, it does not eliminate the possibility entirely, underscoring the importance of open communication and consent with partners regarding sexual health and practices.
Related FAQs and articles
These related FAQs and articles show how Genital Herpes Suppression Therapy can appear in HIV, HPV, HSV, and disclosure.
